Skip to content
  • Company
  • Technology
  • Pipeline
  • Team
  • News
  • Contact

Development of a Novel Immunotherapeutic for Acute Myeloid Leukemia

Posted on June 12, 2024May 12, 2025 by admin
Posted in Uncategorized

Post navigation

Next: Novel Therapies for AML and other Cancers

Recent Posts

  • Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models
  • Development of a Novel Armored CAR-T Immunotherapeutic for Pancreatic Cancer
  • National Academy of Inventors Honors Emory’s Ned Waller
  • Honorees – Emory University
  • Novel Therapies for AML and other Cancers

Recent Comments

No comments to show.

Archives

  • July 2026
  • May 2025
  • January 2025
  • June 2024

Categories

  • Uncategorized
  • Company
  • Technology
  • Pipeline
  • Team
  • News
  • Contact

© 2025 Cambium Oncology. All Rights Reserved - Discloure